federal_register: 2021-28386
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-28386 | Statement of Organization, Functions, and Delegations of Authority | Notice | The Food and Drug Administration's (FDA), Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Tobacco Products (CTP) have modified their organizational structures. These new organizational structures were approved by the Deputy Secretary of Health and Human Services and effective on November 24, 2021. | 2022-01-03 | 2022 | 1 | https://www.federalregister.gov/documents/2022/01/03/2021-28386/statement-of-organization-functions-and-delegations-of-authority | https://www.govinfo.gov/content/pkg/FR-2022-01-03/pdf/2021-28386.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration's (FDA), Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Tobacco Products (CTP) have modified their... |